Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Tevogen Bio Holdings Inc. (TVGN)

1.0750
+0.0350
+(3.38%)
As of 12:28:44 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
53,564.4880
53,564.4880
8,843.0250
953.0830
4,618.4620
Operating Income
-53,564.4880
-53,564.4880
-8,843.0250
-953.0830
-4,618.4620
Net Non Operating Interest Income Expense
-184.0370
-184.0370
-1,206.3520
0
-598.5020
Other Income Expense
40,021.1450
40,021.1450
-50,428.3030
5,361.4440
-10,379.8340
Pretax Income
-13,727.3800
-13,727.3800
-60,477.6800
4,408.3610
-15,596.7980
Net Income Common Stockholders
-13,727.3800
-13,727.3800
-60,477.6800
4,408.3610
-15,596.7980
Diluted NI Available to Com Stockholders
-13,727.3800
-13,727.3800
-60,477.6800
4,408.3610
-15,596.7980
Basic EPS
-0.07
-0.07
-0.38
0.04
-0.13
Diluted EPS
-0.07
-0.07
-0.38
0.04
-0.13
Basic Average Shares
146,672.5340
146,672.5340
165,421.0840
119,999.9890
119,999.9890
Diluted Average Shares
146,672.5340
146,672.5340
165,421.0840
119,999.9890
119,999.9890
Total Operating Income as Reported
-53,564.4880
-53,564.4880
-8,843.0250
-13,724.0640
-4,618.4620
Total Expenses
53,564.4880
53,564.4880
8,843.0250
953.0830
4,618.4620
Net Income from Continuing & Discontinued Operation
-13,727.3800
-13,727.3800
-60,477.6800
4,408.3610
-15,596.7980
Normalized Income
-5,279.8470
-5,279.8470
-60,477.6800
172.8202
-15,596.7980
Interest Expense
184.0370
184.0370
1,206.3520
0
598.5020
Net Interest Income
-184.0370
-184.0370
-1,206.3520
0
-598.5020
EBIT
-13,543.3430
-13,543.3430
-59,271.3280
4,408.3610
-14,998.2960
EBITDA
-13,139.7620
-13,139.7620
-58,892.9710
4,408.3610
-14,988.9190
Reconciled Depreciation
403.5810
403.5810
378.3570
230.8230
9.3770
Net Income from Continuing Operation Net Minority Interest
-13,727.3800
-13,727.3800
-60,477.6800
4,408.3610
-15,596.7980
Total Unusual Items Excluding Goodwill
-8,447.5330
-8,447.5330
0
5,361.4440
--
Total Unusual Items
-8,447.5330
-8,447.5330
0
5,361.4440
--
Normalized EBITDA
-4,692.2290
-4,692.2290
-58,892.9710
-953.0830
-14,988.9190
Tax Rate for Calcs
0
0
0
0.0002
0
Tax Effect of Unusual Items
0
0
0
1,125.9032
0
12/31/2021 - 1/5/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GLMD Galmed Pharmaceuticals Ltd.
1.2393
-3.96%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5796
-15.36%
 
SPRC SciSparc Ltd.
0.3396
+9.55%
 
TOVX Theriva Biologics, Inc.
0.6701
-17.27%
 
CAMP CAMP4 THERAPEUTICS CORPORATION
2.0800
-5.00%
 
ENSC Ensysce Biosciences, Inc.
2.0700
+0.98%
 
INAB IN8bio, Inc.
0.1639
-0.36%
 
PHIO Phio Pharmaceuticals Corp.
1.8700
-8.33%
 
PALI Palisade Bio, Inc.
0.7396
-4.91%
 
ALLR Allarity Therapeutics, Inc.
1.0599
+2.90%